Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.
CHLA scientists work toward a new therapy to target resistant leukemia. Their study, recently published in the journal Leukemia, shows that these new CAR-T cells could be the answer to resistant
The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat
Children’s Hospital Los Angeles is the only hospital in Southern California where patients can receive MIBG therapy, a specialized targeted radiation therapy for neuroblastoma.
Sarah Richman, MD, PhD Cancer and Blood Disease Institute Sarah Richman, MD, PhD, investigates the use of chimeric antigen receptor (CAR) T-cell therapy for solid tumors. She and others in the field
LOS ANGELES (Jun. 16, 2020) — Chintan Parekh, MD, of The Saban Research Institute of Children’s Hospital Los Angeles, has led a team of investigators that generated a comprehensive roadmap for how T
Seattle Children’s, with participating members Children’s Hospital Los Angeles, Children’s National Health System and BC Children’s Hospital, has launched CureWorks, an international collaborative of